New blood biomarker identified for status of fatty liver disease: A MedUni Vienna study team has identified the role of a specific subtype of macrophages (white blood cells) in progressive non-alcoholic fatty liver disease. As part of the immune system, these cells have a protective function against fibrosis and liver cirrhosis. At the same time, […]
Obesity fuelling fatty liver disease ‘ticking time-bomb’, warns British Liver Trust: Rocketing rates of obesity are putting millions at risk of an advanced form of fatty liver disease, the charity British Liver Trust is warning on International NASH Day. A record number of people were admitted to hospital with obesity-related conditions in 2020 and without […]
Exercise supports the treatment of non-alcoholic fatty liver disease by impacting on several metabolic pathways in the body, a new study from the University of Eastern Finland shows. Regular HIIT exercise over a period of 12 weeks significantly decreased the study participants’ fasting glucose and waist circumference, and improved their maximum oxygen consumption rate and […]
Read More… from Study sheds light on the benefits of exercise in fatty liver disease
Chronic inflammatory liver disease: lipid-metabolism enzyme a potential factor in new treatment approach: Primary sclerosing cholangitis (PSC) is a rare, chronic, inflammatory disease of the bile ducts and is difficult to treat. Recent studies conducted by MedUni Vienna’s Division of Gastroenterology and Hepatology, under the supervision of Michael Trauner, have shown that the administration of […]
Read More… from Chronic inflammatory liver disease treatment
Gut bacteria markers could be a ‘smoking gun’ for liver disease, according to new research. The findings, published in the journal Nature Medicine, hint at the potential for chemical by-products produced by the microbes living inside us to be used as early warning signs of disease, which could be detected using a simple blood test. An […]
Read More… from Gut microbes could warn of early liver disease